Improving efficiency in clinical trials using auxiliary information: Application of a multi‐state cure model (Q3459944): Difference between revisions

@@ Property / Wikidata QID @@
+Q41587108
@@ Property / Wikidata QID: Q41587108 / rank @@
+Normal rank
@@ Property / cites work @@
+Criteria for the Validation of Surrogate Endpoints in Randomized Experiments
+Normal rank
@@ Property / cites work @@
+Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials
+Normal rank
@@ Property / cites work @@
+Some comments on efficiency gains from auxiliary information for right-censored data
+Normal rank
@@ Property / cites work @@
+Using surrogate failure time data to increase cost effectiveness in clinical trials
+Normal rank
@@ Property / cites work @@
+Using Auxiliary Variables for Improved Estimates of Survival Time
+Normal rank
@@ Property / cites work @@
+Q4839920
@@ Property / cites work: Q4839920 / rank @@
+Normal rank
@@ Property / cites work @@
+A Shrinkage Approach for Estimating a Treatment Effect Using Intermediate Biomarker Data in Clinical Trials
+Normal rank
@@ Property / cites work @@
+Q4654005
@@ Property / cites work: Q4654005 / rank @@
+Normal rank
@@ Property / cites work @@
+Multiple Imputation After 18+ Years
@@ Property / cites work: Multiple Imputation After 18+ Years / rank @@
+Normal rank
@@ Property / cites work @@
+A Measure of the Proportion of Treatment Effect Explained by a Surrogate Marker
+Normal rank